INDEVION Biotechnologies

WELCOME TO INDEVION Biotechnologies

Innovation - Development - Idea Evolution in Biotechnology

>BUSINESS ACTIVITIES<

Recombinant protein and DNA technology and production - Antibody development and production - Cytokine development and production - Bionanotech-based platform technology for drug development - Glycosylation diagnostics and quality control - Transfection technology development - Cell/genome engineering, cell line development

>GENERAL SERVICE PORTFOLIO<

CONTRACT RESEARCH AND DEVELOPMENT
JOINT INTELLECTUAL PROPERTY DEVELOPMENT
BIOSIMILAR DEVELOPMENT
CUSTOM PROTEIN PRODUCTION PURIFICATION CHARACTERISATION
PROTEIN DESIGN AND ENGINEERING
BIOTECH CONSULTATION

Cell Engineering

Bild: Logos

Transgenic cell lines:
Knockouts, Knockins
point mutations
gene fusions
gene tagging
promoter engineering
multi-transgenics

Protein Expression

Bild: Webdesign

Mammalian, CHO HEK HYBRIDOMA CUSTOM
Custom recombinant protein
development, engineering
design, evolution

Biopharmaceuticals

Bild: Printdesign

DRUG Discovery
PLATFORM Technology
BIOSIMILARS
BIOASSAYS
REPORTER cell lines

CORPORATE NEWS

1 May 2012
INDEVION Biotech Ltd obtains contract with UD-Genomed Medical Genomic Technologies Ltd for genome engineering-base cell line development research projects.
1 Aug 2011
INDEVION Biotech Ltd contracted with UD-Genomed Medical Genomic Technologies Ltd for a therapeutic antibody production development project.
1 July 2011
INDEVION Biotech Ltd enters into contract with UD-Genomed Medical Genomic Technologies Ltd for cell line engineering projects.
Bild: Windrad